NMT EasyFit Sensor and Cable usability and data collection
Official title: Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable
Run by GE Healthcare · NCT07394140 · Data updated 2026-11-12
This study tests how well clinicians can use the NMT EasyFit Sensor with the NMT Cable to monitor neuromuscular block in adults during procedures requiring paralytic medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | GE Healthcare Industry-sponsored |
| Locations | 1 site (Loma Linda, California) |
| Status | Recruiting |
| Started | June 18, 2026 |
| Main results expected | October 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT07394140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older undergoing a clinically indicated procedure that requires paralytic medication and planned NMT monitoring with the NMT ElectroSensor.
✕Probably not a fit
Patients unlikely to benefit include those not receiving paralytic medication or not using the NMT ElectroSensor for monitoring.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study collects feedback from clinical users on the functionality and use of the NMT Sensor and NMT Cable, including the collection of raw parameter data from the device. The NMT Sensor non-invasively delivers electrical stimuli to the ulnar nerve and records EMG responses from the adductor pollicis to quantify neuromuscular block. The sensor is designed for single-use and connects to a reusable cable for use with GE HealthCare NMT systems. Participants are adults undergoing procedures that require paralytic medication, with monitoring conducted using the NMT ElectroSensor on the hand/forearm. The study evaluates device usability, data capture quality, and potential workflow implications in a real-world clinical setting.
Why it matters
Potential benefit: If successful, the findings could improve ease of use and reliability of neuromuscular monitoring during procedures requiring paralysis.
How similar studies have gone: Previous work with similar neuromuscular monitoring devices has shown promise in usability and data accuracy, but this exact sensor/cable setup is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Study subject (male or female) is age 18 years or older (≥18 years). 2. Study subject must have the ability to understand and provide written informed consent. 3. Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication. 4. Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm. Exclusion Criteria: 1. Are known to be pregnant. 2. Are breastfeeding. 3. Suffering from an infection(s) that requires isolation. 4. Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject. 5. Subjects requiring rapid sequence induction 6. Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study. 7. Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules). 8. NMT ElectroSensor placed on the foot/ankle
Where it's running
-
Loma Linda University Health
Loma Linda, California, United States Recruiting
Study contacts
- Study coordinator: Melissa McCabe, MD
- Email: mmccabe@llu.edu
- Phone: 909-558-4475
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TwitchView-guided Atracurium Dose Adjustment in ICU Patients
This trial tests whether using a TwitchView EMG monitor to guide atracurium dosing in ICU patients reduces the total amount of the drug given without compromising care.
-
Monitoring neuromuscular blockade in the ICU: a reliability look
This study tests how reliably neuromuscular blockade monitoring works in adult ICU patients who have been given neuromuscular blocking drugs.
-
TOF3D mechanomyograph for monitoring neuromuscular block during anesthesia.
This project will test whether the TOF3D mechanomyograph measures muscle relaxation more precisely than standard acceleromyography in people having surgery under general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.